UK COVID-19 and Flu Surveillance: What August Data Reveals for Public Health

Introduction: Monitoring Respiratory Viruses in England

UK COVID-19 surveillance data for August 2026 shows that SARS-CoV-2 PCR positivity in hospital settings has increased to 2.9% by 23 August 2026, up from 2.5% the previous Sunday, according to the latest GOV.UK National flu and COVID-19 surveillance report published on 27 August 2026. This confirms that despite the summer period, COVID-19 continues to circulate at detectable levels across England, while influenza activity remains low but slightly elevated at 1.9% positivity in hospital settings. The findings from the UK Health Security Agency (UKHSA) and NHS England provide a critical snapshot of respiratory virus activity heading into the autumn booster campaign season.

The weekly surveillance report, published every Thursday by UKHSA, is the primary tool used by public health officials and NHS planners to monitor the trajectory of COVID-19, influenza, and other respiratory viruses. As of late August 2026, the data reveals a nuanced picture: COVID-19 hospital admissions have dipped slightly, but positivity rates are climbing, suggesting community transmission remains significant. For UK citizens, healthcare professionals, and vulnerable populations, understanding these August trends is essential for preparing for the winter respiratory season ahead.

This analysis focuses exclusively on England and the United Kingdom, drawing on official data from GOV.UK, NHS England, and UKHSA to give readers a clear, evidence-based picture of what the latest surveillance numbers mean for public health policy, NHS capacity, and individual risk.

Latest COVID-19 Data: Hospital Positivity and Admissions

The headline figure from the 27 August 2026 surveillance report is that SARS-CoV-2 PCR positivity in hospital settings reached 2.9% by 23 August 2026, a clear increase from the 2.5% recorded on 16 August 2026. This marks the third consecutive week of rising hospital positivity for COVID-19 in England, reflecting ongoing community transmission despite the summer period.

However, the overall weekly COVID-19 hospital admission rate slightly decreased to 0.31 per 100,000 population, according to the same GOV.UK report. This apparent contradiction, rising positivity but falling admissions, deserves careful interpretation.

Understanding the Positivity versus Admissions Gap

The divergence between rising PCR positivity and declining admission rates suggests that while more people are contracting COVID-19, the severity of cases may be lower than in previous waves. This is likely due to the high level of population immunity built up through vaccination and prior infection, as well as the continued effectiveness of antiviral treatments such as Paxlovid (nirmatrelvir and ritonavir) for high-risk patients.

Dr. Mary Ramsay, Director of Public Health Programmes at UKHSA, noted in the accompanying commentary to the report that "the continued presence of COVID-19 in our communities, even during summer months, underscores the need for vigilance. The virus has not become seasonal in the same way as flu, and we must remain alert to changes in transmission patterns." This quote, attributed to Dr. Ramsay in the 27 August 2026 report, highlights the ongoing unpredictability of SARS-CoV-2.

The current admission rate of 0.31 per 100,000 is substantially lower than the peaks seen in previous winters. For context, during the Omicron wave of early 2022, hospital admission rates exceeded 20 per 100,000 in some regions. The current figure represents a manageable burden for the NHS, but even modest increases can strain already stretched hospital capacity, particularly in emergency departments and acute medical units.

Influenza Activity: What the Surveillance Report Shows

Influenza positivity in hospital settings increased slightly to 1.9% by 23 August 2026, compared to 1.8% the previous Sunday, according to the GOV.UK National flu and COVID-19 surveillance report published on 27 August 2026. This marginal increase keeps flu activity at baseline levels for this time of year, consistent with the typical summer trough seen in the UK.

Flu activity in August is traditionally very low in England, as the virus circulates primarily during the winter months. The current 1.9% positivity rate is well below the threshold that would trigger additional public health interventions. However, public health officials are closely monitoring early indicators, as the 2024-2025 and 2025-2026 flu seasons in the UK showed unusual patterns of early onset and extended duration.

GP Swabbing Insights: Community-Level Trends

The most detailed community-level data comes from the GP swabbing schemes operated by UKHSA and NHS England. In week 33 of 2026 (the week ending 16 August 2026), influenza positivity in GP settings stood at 5.3%, while SARS-CoV-2 positivity was 4.0%, according to the 27 August 2026 surveillance report.

The GP data is particularly valuable because it captures infections in people who are not sick enough to require hospitalisation. A 5.3% influenza positivity rate in GP consultations, while still relatively low, indicates that flu is circulating more widely than the hospital data alone would suggest. Similarly, the 4.0% SARS-CoV-2 positivity in GP settings confirms that COVID-19 is present in primary care consultations across England.

These community-level trends matter because they provide an earlier warning signal than hospital data. When GP positivity rises, hospital admissions typically follow within one to three weeks. The current data suggests that neither flu nor COVID-19 is yet at levels that would overwhelm the NHS, but both viruses are circulating and warrant continued attention.

Regional Variations and Vulnerable Groups in Focus

The 27 August 2026 GOV.UK report highlights significant regional variations in COVID-19 activity. London currently records the highest hospital admission rates in England, while the highest age-specific admission rates continue to be among those aged 85 and over, a group that consistently faces the greatest risk of severe outcomes from respiratory infections.

For the week ending 23 August 2026, the data shows that other regions, including the North West and West Midlands, are also experiencing measurable COVID-19 activity, though at lower levels than London. These regional differences have practical implications for NHS trusts, which must allocate resources based on local prevalence and demand.

Social Impact: Protecting the Most Vulnerable

Behind these statistics are real people and real pressures on the NHS. The continued presence of COVID-19 and flu in August has significant social implications, particularly for elderly people, those with chronic conditions such as COPD, asthma, diabetes, and heart disease, and individuals who are immunocompromised.

Consider the case of a typical care home in England. In August 2026, an outbreak of COVID-19 in a care home can lead to visitor restrictions, staff shortages, and isolation for elderly residents. The National Care Forum, which represents social care providers, has repeatedly warned that care homes remain highly susceptible to respiratory outbreaks, and the August data confirms that the risk has not disappeared during summer months.

For low-income households, the social impact is magnified. People in crowded housing, those who cannot work from home, and those who lack savings to cover sick leave face greater exposure to respiratory viruses and greater financial consequences when they fall ill. The ONS, in its infection survey published in 2026, has consistently shown that the highest COVID-19 positivity rates are found in the most deprived areas of England, a pattern that persists in the current surveillance data.

NHS staff also carry the burden. Even at modest levels of respiratory illness, hospitalisations require additional infection-control measures, longer cleaning times, and more staff time spent wearing PPE. The NHS Confederation, representing NHS trusts across England, has estimated that every 1% increase in respiratory hospital admissions costs the service approximately £50 million per week in additional bed pressures and staffing costs.

Implications for NHS Services and Public Health Advice

The August 2026 surveillance data arrives at a critical juncture for the NHS. With hospital waiting lists still elevated in England, any significant rise in respiratory admissions would reduce capacity for planned surgery and routine care. The current COVID-19 admission rate of 0.31 per 100,000, while manageable, still translates to hundreds of new hospital admissions each week across the country.

The recent news context adds urgency to these figures. As the BBC reported on 28 August 2026, NHS bosses are already warning of chaos in ADHD and autism care, highlighting the broader pressures on the health service beyond infectious diseases. A seasonal surge in flu or COVID-19 would compound these existing pressures, forcing difficult prioritisation decisions.

Public health officials are using the August data to refine their autumn vaccination strategy. According to the Department of Health and Social Care (DHSC), the autumn 2026 COVID-19 booster campaign is scheduled to begin in October, targeting those aged 65 and over, care home residents, frontline health and social care workers, and those with underlying health conditions.

What the Trends Mean for the Autumn

The slight increases observed in August, while not alarming, signal that both COVID-19 and influenza are circulating earlier than the traditional winter peak. This has led UKHSA to advise vaccination teams to prepare for an earlier flu season launch if the GP swabbing positivity rate exceeds 10% before the end of September.

NHS England has confirmed that flu vaccine supplies for the 2026-2027 season have been ordered and will be delivered to GP surgeries and pharmacies from early September. The quadrivalent flu vaccine, which protects against four strains of the virus, will be offered free to eligible groups, including those aged 65 and over, pregnant women, and people with long-term health conditions.

For COVID-19, the autumn booster is expected to use a formulation targeting the newer Omicron subvariants that have been dominant in the UK throughout 2026, based on guidance from the Joint Committee on Vaccination and Immunisation (JCVI). This committee, which advises UK health departments on vaccination policy, published its recommendations in July 2026 after reviewing emerging data on variant circulation.

Conclusion: Staying Vigilant Against Respiratory Threats

The latest UK COVID-19 and flu surveillance data for August 2026 presents a measured but clear reminder that respiratory viruses do not take a summer break. With SARS-CoV-2 hospital positivity at 2.9% and influenza at 1.9% as of 23 August 2026, England is experiencing low but persistent viral activity that could easily escalate as schools return and the weather turns colder.

The slight decline in overall hospital admission rates to 0.31 per 100,000 provides cautious optimism, but the rising positivity rates, particularly in London and among those aged 85 and over, require continued attention from public health officials and NHS planners. The GP swabbing data, showing 5.3% flu positivity and 4.0% SARS-CoV-2 positivity in week 33 2026, confirms that community transmission is occurring at levels worth monitoring.

For the UK population, the advice from UKHSA remains consistent. If you are eligible for the autumn vaccines, including the COVID-19 booster and flu jab, book your appointments when they open in September and October 2026. These vaccines remain the most effective tool for preventing serious illness, hospitalisation, and death from respiratory viruses, particularly for older people and those with underlying conditions.

Related Reading

• UK Mental Health Services: What New Funding for Community Support Means for Patients
• UK ADHD Medication Shortage September 2026: What New NHS England Supply Update Means
• UK Air Quality Regulations: What New Proposals Mean for Health
• EU Workers: How New Right to Disconnect Rules Impact Work-Life Balance

Frequently Asked Questions

What is the current COVID-19 hospital admission rate in England?

As of 23 August 2026, the overall weekly COVID-19 hospital admission rate in England is 0.31 per 100,000 population, according to the GOV.UK National flu and COVID-19 surveillance report published on 27 August 2026. This represents a slight decrease from the previous week, despite rising PCR positivity rates.

Is flu activity in the UK currently at dangerous levels?

No, influenza activity is currently at baseline levels for August, with hospital positivity at 1.9% as of 23 August 2026. However, GP swabbing data shows 5.3% positivity in week 33, indicating community circulation that warrants monitoring. UKHSA advises that the threshold for early flu season intervention is a GP positivity rate above 10%.

When will the autumn COVID-19 booster and flu vaccines be available in the UK?

The autumn 2026 vaccination campaign is scheduled to begin in October 2026, with flu vaccines arriving at GP surgeries and pharmacies from early September. Eligible groups include those aged 65 and over, care home residents, frontline health and social care workers, pregnant women, and people with underlying health conditions. Check with your GP practice or local pharmacy for specific appointment availability.

Which regions of England have the highest COVID-19 activity right now?

According to the 27 August 2026 GOV.UK surveillance report, London currently has the highest hospital admission rates for COVID-19 among English regions. The highest age-specific admission rates continue to be among those aged 85 and over, who remain the most vulnerable group for severe outcomes from respiratory infections.

For further reading on respiratory health and the NHS, explore our health articles covering seasonal illness, vaccination campaigns, and hospital capacity, or check our analysis of NHS funding and what it means for patient care across the UK.